Nanomedicines targeting immunocytes in the tumor microenvironment benefit lung cancer therapy. (IMAGE)

Tsinghua University Press

Nanomedicines targeting immunocytes in the tumor microenvironment benefit lung cancer therapy.

Caption

Nanomedicines exhibit diverse material selections and compositional structures. When targeting the immune cells in the TME, nanomedicines regulate the phenotypes and functions of immune cells through distinct mechanisms. In addition, delivery via immune cell internalization and immune cell membrane coating are also effective approaches to enhance precise targeting.

Credit

Nano Research, Tsinghua University Press

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.